Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | Growth Hormone Releasing Hormone Analog Tesamorelin |
|---|---|
| Summary | The visceral-fat peptide — FDA-approved for HIV-associated lipodystrophy. |
| Mechanism | A stabilized GHRH analog. Selectively reduces visceral adipose tissue in studied populations. |
| Top outcomes |
|
| Evidence | established |
| Half-life | ~26 min (peptide), but downstream GH effect lasts hours |
| Administration | subq |
| Legal status | rx only |
| Safety | Generally well tolerated; injection-site reactions most common. |